[NBIX] QoQ Quarter Result on 30-Jun-2018 [#Q2]

Stock
[NBIX] Neurocrine Biosciences, Inc.
Announcement Date
31-Jul-2018
Financial Year
2018
Quarter
30-Jun-2018 [#Q2]
Profit Trend
QoQ- 85.86%
YoY- 90.14%
Quarter Report
NBIX's Result
NBIX's Financial Summary
View:
Show?
Quarter Result
31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 CAGR
Revenue 138,403 131,492 151,757 96,905 71,086 94,517 60,774 73.18%
PBT -102,594 18,808 50,764 -5,913 -41,818 6,894 -11,125 340.35%
Tax -479 730 7,672 7,591 7,504 6,686 7,337 -
NP -102,115 18,078 50,764 -5,913 -41,818 6,894 -11,125 338.98%
Tax Rate - -3.88% -15.11% - - -96.98% - -
Total Cost 240,518 113,414 100,993 102,818 112,904 87,623 71,899 123.83%
Ratio Analysis
31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 CAGR
NP Margin -73.78 13.75 33.45 -6.10 -58.83 7.29 -18.31 153.43%
Per Share
31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 CAGR
EPS -1.12 0.20 0.56 -0.07 -0.47 0.08 -0.13 320.81%
EPS Diluted -1.12 0.19 0.52 -0.07 -0.47 0.07 -0.13 320.81%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.